# Hyperbaric Oxygen Therapy for Lung Transplantation

> **NCT02363959** · PHASE2 · COMPLETED · sponsor: **Duke University** · enrollment: 20 (actual)

## Conditions studied

- Disorder Related to Lung Transplantation
- Central Airway Stenosis
- Airway Exudative Plaques
- Airway Complications Post-Lung Transplantation

## Interventions

- **DRUG:** Hyperbaric Oxygen Therapy
- **PROCEDURE:** Endobronchial Biopsy of Airway Epithelium

## Key facts

- **NCT ID:** NCT02363959
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2018-09-30
- **Final completion:** 2018-09-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02363959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02363959, "Hyperbaric Oxygen Therapy for Lung Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02363959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*